If you’re living with psoriasis, staying protected against COVID-19 continues to matter — especially as new variants circulate. The U.S. Food and Drug Administration (FDA) has approved a new set of COVID-19 vaccines for the 2025-2026 season, and the Centers for Disease Control and Prevention (CDC) has released updated vaccine guidance.
Sign up to view the results!
Continue with Facebook
Sign up with your email
Here’s what you should know about this year’s booster: how it works, who qualifies, and how to make a plan with your care team.
The COVID-19 vaccines are reformulated each year to better match the most commonly circulating virus strains. For the 2025-2026 season, the FDA directed vaccine manufacturers to update their formulas using a monovalent JN.1 lineage, specifically the LP.8.1 strain.
The FDA has approved 2025-2026 booster formulas for:
The main difference is how they’re made. Pfizer and Moderna use mRNA technology, which gives your cells instructions to make a harmless piece of the virus so your immune system learns to fight it. The Novavx vaccine is protein-based (a more traditional vaccine type). It delivers a purified piece of the virus protein with an adjuvant to boost your immune response.
For most people, any of the three options offers similar protection against severe illness. All are approved for high-risk groups, including people with psoriasis.
COVID-19 doesn’t just affect the lungs. It can trigger widespread inflammation and disrupt how the immune system works — potentially leading to complications throughout the body. For some people living with psoriasis or psoriatic arthritis, especially those taking certain medications or experiencing a flare, the impact can be more serious.
People with psoriasis may be at higher risk for severe illness from COVID-19 if:
While most people recover fully from a COVID-19 infection, some develop long COVID, a condition where symptoms persist or reappear weeks or even months after the initial infection. These may include fatigue, brain fog, shortness of breath, and joint pain.
There are treatments available for COVID-19, including antiviral medications like nirmatrelvir/ritonavir (Paxlovid), remdesivir (Veklury), and molnupiravir (Lagevrio). These treatments work best when started early — ideally within the first few days of symptoms.
Not everyone can take these medications. They may interact with other prescriptions or be unsafe for people with certain health conditions. Your doctor can help determine whether one of these treatments is right for you.
Leading health experts strongly recommend that people living with psoriasis or psoriatic arthritis stay up to date with their COVID-19 vaccines — especially if they’re taking immune-modifying medications or have other risk factors for severe illness.
According to the National Psoriasis Foundation’s (NPF) COVID-19 Task Force, getting vaccinated is the best way to lower your risk of serious complications from COVID-19, including hospitalization and long COVID. While most people with psoriasis are not at increased risk of severe illness just because of their diagnosis, certain factors — such as being in a flare or taking specific medicines — can raise the risk.
The NPF and other health experts recommend that people with psoriasis:
Separately, the CDC’s Advisory Committee on Immunization Practices (ACIP) has recommended that people decide whether to get a COVID-19 vaccination based on individual decision-making. This approach is similar to guidance around the annual flu shot: You and your doctor can work together to decide what’s right for you.
If you’re considering the updated COVID-19 vaccine, here are important timing steps to talk through with your care team:
You can also add extra layers of protection by:
These added steps help lower your risk during treatment weeks or in high-risk situations.
Every person’s journey is different — and so is their COVID-19 risk. Your care team can help you figure out:
Bringing the FDA guidance with you to your next doctor visit can be helpful. It gives you and your provider a starting point to talk about timing, eligibility, and any questions you may have.
If the CDC recommends a COVID-19 booster for you, most insurance plans — including Medicare, Medicaid, and private health insurance — will cover it at no cost. This includes the updated vaccines for the 2025-2026 season. Coverage generally applies as long as the shot is given by a provider in your insurance network.
That said, plan details can vary. Call your insurance provider or check your plan’s website to confirm coverage and avoid any surprises. If you don’t have medical insurance, free COVID-19 vaccines may still be available through public health clinics or federal programs.
On MyPsoriasisTeam, people share their experiences with psoriasis, get advice, and find support from others who understand.
What influenced your choice to get — or not get — the new COVID-19 booster? Let others know in the comments below.
Get updates directly to your inbox.
Continue with Facebook
Sign up with your email
Become a member to get even more
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.